
1. antimicrob agents chemother. 2012 mar;56(3):1382-9. doi: 10.1128/aac.05280-11.
epub 2012 jan 9.

discordant temporal evolution pfcrt pfmdr1 genotypes plasmodium
falciparum vitro drug susceptibility 4-aminoquinolines drug policy
change french guiana.

legrand e(1), yrinesi j, ekala mt, péneau j, volney b, berger f, bouchier c,
bertani s, musset l, meynard jb, mercereau-puijalon o.

author information: 
(1)institut pasteur de la guyane, centre national de référence sur la
chimiorésistance du paludisme dans la région antilles—guyane, cayenne, french
guiana. elegrand@pasteur-cayenne.fr

analysis evolution drug target genes changing drug policy is
needed assist monitoring plasmodium falciparum drug resistance the
field. genotype pfcrt pfdmr1 700 isolates collected french
guiana 2000 (5 years withdrawal chloroquine) 2008, i.e., the
period artemether-lumefantrine combination progressively introduced 
and mefloquine abandoned. gene sequencing showed fixation 7g8-type
pfcrt smvnt resistance haplotype near fixation nycdy pfdmr1 haplotype.
pfdmr1 gene copy number correlated 50% inhibitory concentrations of
mefloquine halofantrine (r = 0.64 0.47, respectively, n = 547); its
temporal changes paralleled changes vitro mefloquine susceptibility.
however, molecular parameters studied account regained in
vitro susceptibility chloroquine showed poor correlation with
susceptibility artemether, lumefantrine, quinine. identification novel
markers resistance antimalarials needed south american
area.

doi: 10.1128/aac.05280-11 
pmcid: pmc3294927
pmid: 22232280  [indexed medline]

